| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yasuyuki Takai, Akiko Yamagami, Mayumi Iwasa, Kenji Inoue, Masato Wakakura, Toshiyuki Takahashi, Keiko Tanak. Clinical Features and Prognostic Factors in Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis. Neuro-ophthalmology (Aeolus Press). vol 48. issue 2. 2024-03-15. PMID:38487356. |
clinical features and prognostic factors in anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. |
2024-03-15 |
2024-03-17 |
Not clear |
| Yasuyuki Takai, Akiko Yamagami, Mayumi Iwasa, Kenji Inoue, Masato Wakakura, Toshiyuki Takahashi, Keiko Tanak. Clinical Features and Prognostic Factors in Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis. Neuro-ophthalmology (Aeolus Press). vol 48. issue 2. 2024-03-15. PMID:38487356. |
in order to review the clinical features of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis (mogon), we investigated the clinical characteristics, visual function, optical coherence tomography findings, and magnetic resonance imaging of 31 patients (44 eyes). |
2024-03-15 |
2024-03-17 |
Not clear |
| Luca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, Javier V Alvarez, Manel Alberich, Sergio Cabello, Joaquín Castilló, Ingrid Galan, Luciana S Midaglia, Breogan Rodriguez Acevedo, Ana Zabalza, Agustin Pappolla, Neus Mongay Ochoa, Mar Tintore, Jordi Rio, Manuel Comabella, Carmen Tur, Cristina Auger, Jaume Sastre-Garriga, Alex Rovira, Xavier Montalban, Deborah Pareto, Angela Vidal-Jordan. Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. vol 102. issue 7. 2024-03-06. PMID:38447105. |
we aimed to assess the presence of retinal neurodegeneration independent of optic neuritis (on) in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and to investigate the development of trans-synaptic anterograde degeneration in these patients after on. |
2024-03-06 |
2024-03-09 |
Not clear |
| Juan Zhao, Xiaoli Chen, Jingxiao Zhang, Lei Liu, Jiawei Wang, Liping Zh. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Multiple sclerosis and related disorders. vol 85. 2024-03-06. PMID:38447395. |
isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: the importance of age of onset and prognosis-related radiological features. |
2024-03-06 |
2024-03-09 |
Not clear |
| Ryan D Sorensen, Ashtyn Vogt, Noor Laylani, Mohammad Pakravan, Andrew G Le. Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report. BMC ophthalmology. vol 24. issue 1. 2024-02-13. PMID:38350984. |
myelin oligodendrocyte glycoprotein (mog) associated optic neuritis in a patient with idiopathic intracranial hypertension (iih) and compressive optic neuropathy case report. |
2024-02-13 |
2024-02-16 |
Not clear |
| Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, Itay Lotan, Monique Anderson, Gabriela Romanow, Rebecca Salky, Brian C Healy, Marcelo Matiello, Tanuja Chitnis, Michael Lev. Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-02-05. PMID:38314479. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) can cause optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis (adem). |
2024-02-05 |
2024-02-07 |
Not clear |
| Giordani Rodrigues Dos Passos, Tarso Adoni, Maria Fernanda Mendes, Douglas Kazutoshi Sat. Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine. Arquivos de neuro-psiquiatria. vol 81. issue 12. 2023-12-29. PMID:38157878. |
this review explores the impact of precision medicine on various neuroimmunological conditions, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), optic neuritis, autoimmune encephalitis, and immune-mediated neuropathies. |
2023-12-29 |
2024-01-05 |
Not clear |
| Ayob Siti Aeisyah, Nurul Ain Masnon, Rohazly Ismail, Ahmad Rithauddin Mohame. Tumefactive demyelinating lesion and bilateral optic neuritis in a paediatric myelin oligodendrocyte glycoprotein antibody-associated disease. BMJ case reports. vol 16. issue 12. 2023-12-19. PMID:38103908. |
tumefactive demyelinating lesion and bilateral optic neuritis in a paediatric myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-12-19 |
2023-12-21 |
Not clear |
| Takashi Saito, Rieko Suzuki, Noboru Imai, Masahiro Serizaw. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Following Adenovirus Meningitis After First Delivery: Case Report and Literature Review. Cureus. vol 15. issue 11. 2023-12-07. PMID:38060760. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a group of central nervous system (cns) demyelinating diseases caused by autoantibodies against myelin oligosaccharide protein (mog), a myelin sheath component protein, and present with a variety of symptoms, including optic neuritis, myelitis, acute disseminated encephalomyelitis (adem), brainstem encephalitis, and corticobasal encephalitis. |
2023-12-07 |
2023-12-17 |
Not clear |
| Chuan-Bin Su. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection. Frontiers in immunology. vol 14. 2023-12-06. PMID:38054007. |
to evaluate the prevalence of serum myelin oligodendrocyte glycoprotein antibody (mog-ab) and aquaporin-4 antibody (aqp4-ab) in optic neuritis (on) patients after severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection by cell-based indirect immunofluorescence assay (cba). |
2023-12-06 |
2023-12-10 |
Not clear |
| Giuseppe Schirò, Salvatore Iacono, Michele Andolina, Alessia Bianchi, Paolo Ragonese, Giuseppe Salem. Tocilizumab treatment in MOGAD: a case report and literature review. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-11-27. PMID:38010585. |
myelin oligodendrocyte glycoprotein-immunoglobulin g associated disease (mogad) is an autoimmune demyelinating disorder of the central nervous system (cns) which usually occurs with recurrent optic neuritis, transverse myelitis, acute disseminating encephalomyelitis, or brainstem encephalitis. |
2023-11-27 |
2023-11-29 |
Not clear |
| Durgadevi Parthasarathy, Kulandai Lily Therese, Selvakumar Ambika, Selvi Krishnan, Durga Priyadarshini Santhakuma. Simultaneous screening for antibodies to myelin oligodendrocyte glycoprotein and aquaporin-4 in patients with optic neuritis using cell-based assay. Current journal of neurology. vol 21. issue 1. 2023-11-27. PMID:38011487. |
simultaneous screening for antibodies to myelin oligodendrocyte glycoprotein and aquaporin-4 in patients with optic neuritis using cell-based assay. |
2023-11-27 |
2023-11-29 |
Not clear |
| Kayla Martin, Priya Srikanth, Anand Kanwar, Julie Falardeau, David Pettersson, Vijayshree Yada. Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Multiple sclerosis and related disorders. vol 81. 2023-11-18. PMID:37979410. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a newly described clinical entity comprised of isolated or recurrent attacks of optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (adem), encephalitis, or seronegative nmosd. |
2023-11-18 |
2023-11-20 |
human |
| Giacomo Greco, Elena Colombo, Matteo Gastaldi, Lara Ahmad, Eleonora Tavazzi, Roberto Bergamaschi, Eleonora Rigon. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis. International journal of molecular sciences. vol 24. issue 21. 2023-11-14. PMID:37958968. |
beyond myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: alternative causes of optic neuritis. |
2023-11-14 |
2023-11-20 |
Not clear |
| Mohamad Azlan Zaini, Ayesha Mohd Zain, Norshamsiah Md Din, Chenshen La. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient. Immunity, inflammation and disease. vol 11. issue 10. 2023-10-31. PMID:37904693. |
myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-covid-19 infection patient. |
2023-10-31 |
2023-11-08 |
Not clear |
| Mohamad Azlan Zaini, Ayesha Mohd Zain, Norshamsiah Md Din, Chenshen La. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient. Immunity, inflammation and disease. vol 11. issue 10. 2023-10-31. PMID:37904693. |
we report a case of myelin oligodendrocyte glycoprotein (mog) related optic neuritis in a sars-cov-2 (covid-19) patient. |
2023-10-31 |
2023-11-08 |
Not clear |
| Emilie Bergeron, Marc A Bouffar. Evidence-based management of optic neuritis. Current opinion in ophthalmology. 2023-10-17. PMID:37846574. |
optic neuritis can result from several distinct causes, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody disease (mogad), when not idiopathic. |
2023-10-17 |
2023-11-08 |
Not clear |
| Armin Handzic, Sumana Naidu, Natalie Brossard-Barbosa, Edward Margoli. Poor Visual Outcome After First Attack in a Cohort of Patients With Myelin Oligodendrocyte Glycoprotein-Related Optic Neuritis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023-10-12. PMID:37824275. |
poor visual outcome after first attack in a cohort of patients with myelin oligodendrocyte glycoprotein-related optic neuritis. |
2023-10-12 |
2023-10-15 |
Not clear |
| Armin Handzic, Sumana Naidu, Natalie Brossard-Barbosa, Edward Margoli. Poor Visual Outcome After First Attack in a Cohort of Patients With Myelin Oligodendrocyte Glycoprotein-Related Optic Neuritis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023-10-12. PMID:37824275. |
myelin oligodendrocyte glycoprotein-associated optic neuritis (mog-on) is typically a highly treatable condition that responds quickly to treatment with high doses of corticosteroids. |
2023-10-12 |
2023-10-15 |
Not clear |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
we are reporting a case of a middle-aged adult diagnosed with myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis of the right eye post-covid-19 disease. |
2023-10-09 |
2023-10-15 |
Not clear |